The position involves a strong focus on improving the estimation of burden of disease. Read more...
Act now: Contact your MEP and ask them to support and ask ECDA's questions to Commissioners designate
Read the global policy and civil society report on prevention and control of viral hepatitis
Now 4060 members from 106 countries
Latest news
European Chronic Disease Alliance (ECDA)
  EASL is a member of the European Chronic Disease Alliance (ECDA), which has put together a list of questions to Commissioners designate. These have been sent to all of the Committees in the European Parliament who cover the relevant issues of interest to the ECDA and its [...] Read more
HCV Quest, a new global patient survey focusing on mono-infected patients with hepatitis C (HCV) and developed by the World Hepatitis Alliance has so far received responses from 45 countries, highlighting the medical, economic and psychological burden of hepatitis C. The [...] Read more
  I would like to make you aware of a job announcement within the WHO Global Hepatitis Programme team for a Hepatitis Treatment Medical Officer. The announcement closes on 15 September 2014 and details about the job can be found on the WHO web site [...] Read more
The Official Journal of the European Union (OJ)
Dods EU Alert Please click here to access Calls for proposals and related activities under the ERC Work Programme 2015 under Horizon 2020 — the Framework Programme for Research and Innovation (2014-2020). [...] Read more
EASL’s flagship publication, the Journal of Hepatology has been awarded an Impact Factor of 10.401. According to Thomson Reuters, these results make the Journal of Hepatology the fastest growing and most consistently impactful hepatology publication over the past 8 years. This [...] Read more
On World Hepatitis Day, organisations call on SA government: protect infants with HepB jab at birth & reduce patent barriers to HepB therapies July 28, 2014, JOHANNESBURG—On World Hepatitis Day, 22 organisations and individuals from around the world have called on the South [...] Read more
Innovative Medicines Initiative (IMI)
There is nothing so far in IMI for liver disease but it is a really big piece of the Horizon 2020 research agenda so it would be good if we could put a link on this on our social media sites. Maybe one of our members will have a research idea that links liver disease with [...] Read more
Italian Presidency of the Council of the European Union
The Italian Presidency of the Council of the European Union has published its 2014 health priorities including; cancer, vaccines, a review of measures regulating the prices of medicinal products and a wide ranging reflection on health in the Mediterranean area.  The intention is [...] Read more
European Parliament Register
Question for written answer E-005504/2014 to the Commission Rule 117 Sergio Paolo Francesco Silvestris (PPE) Subject: Low profile of liver diseases According to some estimates, liver diseases, and cirrhosis of the liver in particular, are extremely costly in terms of human [...] Read more
European Parliament Register
Source: European Parliament Register Subject: Answer to a written question on Medicines and side effects on the liver Date published: June 20 2014 Question for written answer E-005505/2014 to the Commission Rule 117 Sergio Paolo Francesco Silvestris (PPE) Subject: [...] Read more